» Articles » PMID: 30807742

The Role of Lysosomal Cysteine Cathepsins in NLRP3 Inflammasome Activation

Overview
Publisher Elsevier
Specialties Biochemistry
Biophysics
Date 2019 Feb 27
PMID 30807742
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Lysosomal cysteine cathepsins are a family of proteases that are involved in a myriad of cellular processes from proteolytic degradation in the lysosome to bone resorption. These proteins mature following the cleavage of a pro-domain in the lysosome to become either exo- or endo-peptidases. The cathepsins B, C, L, S and Z have been implicated in NLRP3 inflammasome activation following their activation with ATP, monosodium urate, silica crystals, or bacterial components, among others. These five cathepsins have both compensatory and independent functions in NLRP3 inflammasome activation. There is much evidence in the literature to support the release of cathepsin B following lysosomal membrane degradation which leads to NLRP3 inflammasome activation. This is likely due to a hitherto unidentified role of this protein in the cytoplasm, although other interactions with autophagy proteins and within lysosomes have been proposed. Cathepsin C is involved in the processing of neutrophil IL-1β through processing of upstream proteases. Cathepsin Z is non-redundantly required for NLRP3 inflammasome activation following nigericin, ATP and monosodium urate activation. Lysosomal cysteine cathepsins are members of a diverse and complementary family, and likely share both overlapping and independent functions in NLRP3 inflammasome activation.

Citing Articles

Lysosome targeted therapies in hematological malignancies.

Manivannan M, Peters A, Gibson S Front Oncol. 2025; 15:1549792.

PMID: 40066097 PMC: 11891156. DOI: 10.3389/fonc.2025.1549792.


Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy.

Conesa-Bakkali R, Morillo-Huesca M, Martinez-Fabregas J Cells. 2025; 14(2).

PMID: 39851495 PMC: 11763575. DOI: 10.3390/cells14020068.


Revealing the dance of NLRP3: spatiotemporal patterns in inflammasome activation.

Spector L, Subramanian N Immunometabolism (Cobham). 2025; 7(1):e00053.

PMID: 39816134 PMC: 11731036. DOI: 10.1097/IN9.0000000000000053.


miR-21 and cathepsin B in familial Mediterranean fever: novel findings regarding their impact on disease severity.

Durmus S, Gelisgen R, Hajiyeva R, Adrovic A, Yildiz M, Yucesan E BMJ Paediatr Open. 2025; 9(1.

PMID: 39779193 PMC: 11749570. DOI: 10.1136/bmjpo-2024-003064.


Are cathepsins a risk factor for papillary thyroid carcinoma? A bidirectional two-sample mendelian randomization analysis.

Sun Z, Chen H, Li C, Yang H, Ling J, Chang A Eur Arch Otorhinolaryngol. 2025; .

PMID: 39757267 DOI: 10.1007/s00405-024-09176-w.